These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11898181)

  • 1. Genetic testing for prostate cancer. Willingness and predictors of interest.
    Diefenbach MA; Schnoll RA; Miller SM; Brower L
    Cancer Pract; 2000; 8(2):82-6. PubMed ID: 11898181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interest in, willingness-to-pay for and willingness-to-recommend genetic testing for prostate cancer among affected men after radical prostatectomy.
    Mayer M; Selig K; Tüttelmann F; Dinkel A; Gschwend JE; Herkommer K
    Fam Cancer; 2019 Apr; 18(2):221-230. PubMed ID: 30229510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interest in genetic testing among affected men from hereditary prostate cancer families and their unaffected male relatives.
    Harris JN; Bowen DJ; Kuniyuki A; McIntosh L; FitzGerald LM; Ostrander EA; Stanford JL
    Genet Med; 2009 May; 11(5):344-55. PubMed ID: 19346959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer.
    Bratt O; Damber JE; Emanuelsson M; Kristoffersson U; Lundgren R; Olsson H; Grönberg H
    Eur J Cancer; 2000 Jan; 36(2):235-41. PubMed ID: 10741283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worry and attitude of men in at-risk families for prostate cancer about genetic susceptibility and genetic testing.
    Cormier L; Valéri A; Azzouzi R; Fournier G; Cussenot O; Berthon P; Guillemin F; Mangin P
    Prostate; 2002 Jun; 51(4):276-85. PubMed ID: 11987156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beliefs, and reported and intended behaviors of unaffected men in response to their family history of prostate cancer.
    Cowan R; Meiser B; Giles GG; Lindeman GJ; Gaff CL
    Genet Med; 2008 Jun; 10(6):430-8. PubMed ID: 18496220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Men's attitudes regarding genetic testing for hereditary prostate cancer risk.
    Miesfeldt S; Jones SM; Cohn W; Lippert M; Haden K; Turner BL; Martin-Fries T; Clark SM
    Urology; 2000 Jan; 55(1):46-50. PubMed ID: 10654893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes toward colon cancer gene testing: survey of relatives of colon cancer patients.
    Petersen GM; Larkin E; Codori AM; Wang CY; Booker SV; Bacon J; Giardiello FM; Boyd PA
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):337-44. PubMed ID: 10207638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interest in genetic prostate cancer susceptibility testing among african American men.
    Weinrich S; Royal C; Pettaway CA; Dunston G; Faison-Smith L; Priest JH; Roberson-Smith P; Frost J; Jenkins J; Brooks KA; Powell I
    Cancer Nurs; 2002 Feb; 25(1):28-34. PubMed ID: 11838717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sons of men with prostate cancer: their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testing.
    Bratt O; Kristoffersson U; Lundgren R; Olsson H
    Urology; 1997 Sep; 50(3):360-5. PubMed ID: 9301698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographics, family histories, and psychological characteristics of prostate carcinoma screening participants.
    Taylor KL; DiPlacido J; Redd WH; Faccenda K; Greer L; Perlmutter A
    Cancer; 1999 Mar; 85(6):1305-12. PubMed ID: 10189136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups.
    Glanz K; Grove J; Lerman C; Gotay C; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):329-36. PubMed ID: 10207637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attitudes toward colon cancer gene testing: factors predicting test uptake.
    Codori AM; Petersen GM; Miglioretti DL; Larkin EK; Bushey MT; Young C; Brensinger JD; Johnson K; Bacon JA; Booker SV
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):345-51. PubMed ID: 10207639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of prostate-specific antigen (PSA) testing in Australian men: the influence of family history.
    McDowell ME; Occhipinti S; Gardiner RA; Chambers SK
    BJU Int; 2012 Apr; 109 Suppl 3():64-70. PubMed ID: 22458497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men.
    Hevey D; Pertl M; Thomas K; Maher L; Chuinneagáin SN; Craig A
    Patient Educ Couns; 2009 Feb; 74(2):244-9. PubMed ID: 18848753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding of multigene test results among males undergoing germline testing for inherited prostate cancer: Implications for genetic counseling.
    Giri VN; Obeid E; Hegarty SE; Gross L; Bealin L; Hyatt C; Fang CY; Leader A
    Prostate; 2018 Sep; 78(12):879-888. PubMed ID: 29655297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and predictors of cancer specific distress in men with a family history of prostate cancer.
    McDowell ME; Occhipinti S; Gardiner RA; Chambers SK
    Psychooncology; 2013 Nov; 22(11):2496-504. PubMed ID: 23712946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost sharing and hereditary cancer risk: predictors of willingness-to-pay for genetic testing.
    Matro JM; Ruth KJ; Wong YN; McCully KC; Rybak CM; Meropol NJ; Hall MJ
    J Genet Couns; 2014 Dec; 23(6):1002-11. PubMed ID: 24794065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of the use of alternative therapies by men with localized prostate cancer.
    Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
    Patient Educ Couns; 2004 Oct; 55(1):70-7. PubMed ID: 15476992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
    Geller G; Doksum T; Bernhardt BA; Metz SA
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.